Immupharma Plc (IMM.L)
88.25GBp
16 Dec 2009
-1.25p (-1.40%)
89.50p
88.00p
90.00p
87.00p
124,383
192,291
144.00p
54.00p
IMM.L
About
Overall
| Beta: | 0.32 |
| Market Cap (Mil.): | £68.38 |
| Shares Outstanding (Mil.): | 77.48 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| IMM.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 15.44 | 12.32 | 4.67 |
| EPS (TTM): | 234.43 | -- | -- |
| ROI: | 60.71 | 1.59 | 2.82 |
| ROE: | 65.47 | 2.36 | 3.52 |
UPDATE 5-Cephalon stock drops after trial data disappoint
* Cephalon delays decision on Ception acquisition (Adds detail in paragraph 5, updates share price)
UPDATE 2-ImmuPharma CEO slams stock plunge after drug trial
* CEO says measure not important, too many people included
STOCKS NEWS EUROPE-ImmuPharma sinks after trial data
Shares in Lupus specialist ImmuPharma sink nearly 20 percent after the company reports interim results for its lead drug Lupuzor.
STOCKS NEWS UK-ImmuPharma plummets after trial data
STOCKS NEWS Reuters Results diary
UPDATE 1-ImmuPharma swings to H1 profit after Cephalon deal
* Company had 27 mln stg cash at its half-year point (Adds details)
Specialty drugmakers circle wounded biotechs
BOSTON (Reuters) - As the crisis in the biotech sector deepens, opportunities abound for companies looking to acquire cheap assets.
CORRECTED - DEALTALK-Specialty drugmakers circle wounded biotechs
(For more Reuters Dealtalks, double-click on [DEALTALK/]) (Corrects sixth paragraph to say "one year of cash or less" instead of "one year of cash")
STOCKS NEWS EUROPE-Fiat soars on UBS note, CEO interviews
STOCKS NEWS Reuters Results diary
Hot small caps - Immupharma jumps on deal with Cephalon
LONDON (Reuters) - Following is a round-up of key small cap movers on the London stock market on Tuesday.
CORRECTED - STOCKS NEWS EUROPE-Turkcell up on Vodafone Turkish woes
STOCKS NEWS Reuters Results diary
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
